Data as of Nov 25
| -0.14 / -0.61%|
The 3 analysts offering 12-month price forecasts for Repligen Corp have a median target of 25.00, with a high estimate of 26.00 and a low estimate of 25.00. The median estimate represents a +9.94% increase from the last price of 22.74.
The current consensus among 3 polled investment analysts is to Buy stock in Repligen Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.